Óxido de zinc, ROTI®nanoMETIC, mínimo 99 %, 25 nm, 50 g, envase de vidrio

4-(Difluoromethoxy)-3-hydroxybenzoic acid, 95.0%, 1g

1-(1H-indol-5-yl)ethanamine, 95.0%, 250mg

2-Chloro-3,5-dimethylbenzoic acid, 500mg

N1-(2-Methylnaphthalen-1-yl)-N2-(pyridin-2-ylmethyl)oxalamide, 98%, 1g

(E)-4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)styryl)-1,3,2-dioxaborolane, 95+%, 250mg

Methyl 4-(piperidin-4-yl)benzoate hydrochloride, 95.0%, 250mg

3-METHOXY-N-(1-METHYLPIPERIDIN-4-YL)-4-((4-((3-OXO-2,3-DIHYDRO-1H-INDEN-4-YL)OXY)-5-(TRIFLUOROMETHYL)PYRIMIDIN-2-YL)AMINO)BENZAMIDE, 95%, 250mg

Octahydropiperazino[1,2-c][1,3]oxazin-6-one hydrochloride, 98%, 1g

Methyl 5-aminopyridine-2-carboxylate, 98.0%, 25g

1-(diazyn-1-ium-1-yl)-4,7,10,13-tetraoxa-1-azatetradecan-1-ide, >98.0%(HPLC), 25mg

(R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one, 95.0%, 25g

2-(3-Bromophenyl)-1,1,1-trifluoropropan-2-ol, 95%, 100mg